Pfizer will request the authorization of its vaccine against COVID-19 for children between 6 months and 5 years
2/1/2022, 7:42:45 PM
The pharmaceutical company announced that it will soon submit to the FDA the proposal for immunization of two doses of its vaccine for this group, which could take place at the end of February. If approved for emergency use, it will benefit 19 million children.